251 related articles for article (PubMed ID: 21642828)
1. Implications of over-the-counter proton pump inhibitors for patient counseling by pharmacists.
Simonson W
Am J Ther; 2013; 20(6):676-84. PubMed ID: 21642828
[TBL] [Abstract][Full Text] [Related]
2. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors.
Boardman HF; Heeley G
Int J Clin Pharm; 2015 Oct; 37(5):709-16. PubMed ID: 26100836
[TBL] [Abstract][Full Text] [Related]
3. Partnership in optimizing management of reflux symptoms: a treatment algorithm for over-the-counter proton-pump inhibitors.
Boardman HF; Delaney BC; Haag S
Curr Med Res Opin; 2015; 31(7):1309-18. PubMed ID: 25950642
[TBL] [Abstract][Full Text] [Related]
4. The use of nonprescription medicines among elderly patients with chronic illness and their need for pharmacist interventions.
Guirguis K
Consult Pharm; 2010 Jul; 25(7):433-9. PubMed ID: 20601348
[TBL] [Abstract][Full Text] [Related]
5. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.
Johnson DA; Katz PO; Armstrong D; Cohen H; Delaney BC; Howden CW; Katelaris P; Tutuian RI; Castell DO
Drugs; 2017 Apr; 77(5):547-561. PubMed ID: 28233274
[TBL] [Abstract][Full Text] [Related]
6. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
[TBL] [Abstract][Full Text] [Related]
7. Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.
Holtmann G; Bigard MA; Malfertheiner P; Pounder R
Int J Clin Pharm; 2011 Jun; 33(3):493-500. PubMed ID: 21472476
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based treatment of frequent heartburn: the benefits and limitations of over-the-counter medications.
McRorie JW; Gibb RD; Miner PB
J Am Assoc Nurse Pract; 2014 Jun; 26(6):330-9. PubMed ID: 24825071
[TBL] [Abstract][Full Text] [Related]
9. Assessing student pharmacist impact on patient over-the-counter medication selection.
McConaha JL; Finoli LM; Heasley JE; Lunney PD
J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of OTC omeprazole].
Labenz J; Willmer C
MMW Fortschr Med; 2012 Dec; 154 Suppl 4():110-4. PubMed ID: 23326929
[TBL] [Abstract][Full Text] [Related]
11. Role of the primary care provider in the diagnosis and management of heartburn.
Kushner PR
Curr Med Res Opin; 2010 Apr; 26(4):759-65. PubMed ID: 20095795
[TBL] [Abstract][Full Text] [Related]
12. The influence of evidence-based medicine training on decision-making in relation to over-the-counter medicines: a qualitative study.
Hanna LA; Hughes C
Int J Pharm Pract; 2012 Dec; 20(6):358-66. PubMed ID: 23134094
[TBL] [Abstract][Full Text] [Related]
13. Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?
Kushner PR; Peura DA
Adv Ther; 2011 May; 28(5):367-88. PubMed ID: 21484335
[TBL] [Abstract][Full Text] [Related]
14. Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn.
Fendrick AM; Shaw M; Schachtel B; Allgood L; Allgood G; Grender J; Peura D
Clin Gastroenterol Hepatol; 2004 Jan; 2(1):17-21. PubMed ID: 15017628
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
Miner PB; McKean LA; Gibb RD; Erasala GN; Ramsey DL; McRorie JW
Aliment Pharmacol Ther; 2010 Apr; 31(8):846-51. PubMed ID: 20146702
[TBL] [Abstract][Full Text] [Related]
16. Self-Care in the Twenty First Century: A Vital Role for the Pharmacist.
Bell J; Dziekan G; Pollack C; Mahachai V
Adv Ther; 2016 Oct; 33(10):1691-1703. PubMed ID: 27535290
[TBL] [Abstract][Full Text] [Related]
17. Intern pharmacists as change agents to improve the practice of nonprescription medication supply: provision of salbutamol to patients with asthma.
Schneider CR; Everett AW; Geelhoed E; Padgett C; Ripley S; Murray K; Kendall PA; Clifford RM
Ann Pharmacother; 2010; 44(7-8):1319-26. PubMed ID: 20571101
[TBL] [Abstract][Full Text] [Related]
18. Pharmacy placement of nonprescription nicotine replacement therapy products and community pharmacists' counseling for product use.
Kilfoy BA; Prokhorov AV; Hudmon KS
J Am Pharm Assoc (2003); 2006; 46(6):723-8. PubMed ID: 17176688
[TBL] [Abstract][Full Text] [Related]
19. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.
Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM
Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228
[TBL] [Abstract][Full Text] [Related]
20. A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction.
Peura D; Le Moigne A; Pollack C; Nagy P; Lind T
Postgrad Med; 2016 Aug; 128(6):577-83. PubMed ID: 27331882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]